Saturday, July 12, 2025
Khmer Daily Cambodia News
34 °c
Phnom Penh
  • LATEST
  • CAMBODIA
  • ASIA
    • JAPAN
    • SOUTH KOREA
    • TAIWAN
  • WORLD
    • CHINA
    • RUSSIA
  • BUSINESS CAMBODIA
  • TECHNOLOGY
No Result
View All Result
  • LATEST
  • CAMBODIA
  • ASIA
    • JAPAN
    • SOUTH KOREA
    • TAIWAN
  • WORLD
    • CHINA
    • RUSSIA
  • BUSINESS CAMBODIA
  • TECHNOLOGY
No Result
View All Result
The Khmer Daily
No Result
View All Result
Home World

Pfizer begins study of oral drug for prevention of Covid-19

September 30, 2021
in Health, Lifestyle, World
0
Pfizer begins study of oral drug for prevention of Covid-19
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

NEW YORK – Pfizer Inc said on Monday (Sept 27) it has started a large study testing its investigational oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to the virus.

The drugmaker and its rivals, including US-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop an easy-to-administer antiviral pill for Covid-19.

The mid-to-late-stage study will test Pfizer’s drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic Covid-19 infection.

In the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered along with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.

To date, Gilead Sciences Inc’s intravenous drug remdesivir is the only approved antiviral treatment for Covid-19 in the United States.

Pfizer has also started another study of PF-07321332 in non-hospitalised, symptomatic adult patients.

Merck and partner Ridgeback Biotherapeutics recently launched a late-stage trial of their experimental drug molnupiravir for prevention of the Covid-19 infection.

Molnupiravir is also being studied in a late-stage trial in non-hospitalised patients to see if it reduces the risk of hospitalisation or death.

This article was first published in Asia One . All contents and images are copyright to their respective owners and sources.

Tags: #coronavirus#COVID-19#Drugs#study#vaccineshow all tags
Previous Post

Cambodia in sweet spot to increase exports, Indonesian Chamber of Commerce in Cambodia president says

Next Post

2C2P payments platform has announced new partnerships in Cambodia and Vietnam

Related Posts

Neak Poan Temple is a destination for tourists to visit and take beautiful pictures

Neak Poan Temple is a destination for tourists to visit and take beautiful pictures

by Khmer Times
July 3, 2023
0
107

Neak Poan Temple is one of the most attractive tourist destinations among the ancient temples, which is located along the...

Italy to pass ‘right to be forgotten’ law for cancer survivors

Italy to pass ‘right to be forgotten’ law for cancer survivors

by AsiaOne
June 15, 2023
0
25

ROME — Italy will pass a law on the "right to be forgotten" (RTBF) for cancer survivors, Prime Minister Giorgia Meloni...

Bill Gates in China: Microsoft co-founder to meet Xi Jinping

Bill Gates in China: Microsoft co-founder to meet Xi Jinping

by AsiaOne
June 15, 2023
0
40

HONG KONG — Bill Gates, Microsoft Corp's co-founder, is set to meet Chinese President Xi Jinping on Friday (June 16) during his...

Most Popular

New dairy farm in Cambodia, Kirisu, goes into fresh milk production operated by Khmer Fresh Milk

New dairy farm in Cambodia, Kirisu, goes into fresh milk production operated by Khmer Fresh Milk

July 17, 2020
507
Neak Poan Temple is a destination for tourists to visit and take beautiful pictures

Neak Poan Temple is a destination for tourists to visit and take beautiful pictures

July 3, 2023
107

$140 million brewery factory in Cambodia, Vattanac Brewery, will employ 1,500

June 27, 2020
118
Is this Japan’s weirdest mascot? Meet Hokkaido’s Zushihocky, part rice, part clam

Is this Japan’s weirdest mascot? Meet Hokkaido’s Zushihocky, part rice, part clam

May 27, 2020
38
Ezecom, ISP in Cambodia, 14 years of operations to bring World-Class Digital Service for Cambodians

Ezecom, ISP in Cambodia, 14 years of operations to bring World-Class Digital Service for Cambodians

March 26, 2022
28
Phnom Penh-Sihanoukville Expressway (PP-SHV) users to get 20% discount until October 2023

Phnom Penh-Sihanoukville Expressway (PP-SHV) users to get 20% discount until October 2023

November 2, 2022
19

© 2020 By Khmer Daily News

No Result
View All Result
  • Home
  • Latest
  • Cambodia
  • ASIA
  • World
  • Business
  • Tech

© 2019 The Khmer Daily.

error: Content is protected !!